Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

59 results about "Gene Annotation" patented technology

The addition of descriptive information about the function or structure of an RNA or DNA SEQUENCE to its record in a database (NUCLEIC ACID DATABASES.)

Method for detecting variable spliceosome in third generation full-length transcriptome

ActiveCN105389481AEfficient access to shear structuresPerfect commentSequence analysisSpecial data processing applicationsReference genome sequenceGene model
The invention discloses a method for detecting a variable spliceosome in a third generation full-length transcriptome. The method comprises the following steps: merging original annular test sequences with joints removed to form a monomolecular transcript sequence, and screening a third generation full-length transcript sequence; comparing the third generation full-length transcript sequence with a reference genome sequence, and screening a third generation full-length transcript sequence having coverage and similarity with the reference genome sequence larger than preset thresholds; carrying out splicing false positive filtration and DNA contamination filtration on the screened third generation full-length transcript sequence; and carrying out gene annotation and variable spliceosome annotation on the filtered third generation full-length transcript sequence. An overlong read length of a third generation sequencing technology mentioned in the method disclosed by the invention is large enough to cover most RNA, the third generation full-length transcript sequence can be obtained by SMRT sequencing transcriptomes without being assembled, and a splicing structure of a gene can be effectively obtained by third generation transcriptome sequencing, and more perfect gene model annotation can be constructed.
Owner:嘉兴菲沙基因信息有限公司

Metagenome data analysis method based on next-generation sequencing technology

The invention discloses a metagenome data analysis method based on a next-generation sequencing technology, which comprises the following steps of: (1) carrying out quality control on original sequencing data to obtain clean reads; (2) performing species annotation on the clean reads subjected to the quality control; (3) performing statistical analysis on the sample diversity based on a species abundance matrix; (4) performing statistical analysis on species with significant differences among sample groups based on the species abundance matrix; (5) splicing and assembling the clean reads to obtain a contigs sequence; (6) packaging the contigs obtained by splicing and assembling into boxes to obtain bins; (7) carrying out gene annotation on the bins subjected to boxing; (8) performing statistical analysis on the genes with significant differences among the sample groups based on the gene abundance matrix; and (9) based on the gene annotation result, performing function and species annotation on the sequence. A whole process from metagenome next-generation sequencing data processing to species composition analysis, gene composition analysis and function annotation is provided, an accurate analysis result is provided for researchers, and the metagenomics problem is comprehensively analyzed.
Owner:NANKAI UNIV

Method for detecting chromosome microdeletion and micro-duplication of human embryo

The invention relates to a method for detecting chromosome microdeletion and micro-duplication of a human embryo. The method comprises the following steps of performing whole genome amplification on cells cultured in vitro, interrupting DNA (deoxyribonucleic acid) molecules, and sequencing DNA fragments to obtain sequencing reads; comparing the sequencing reads with a reference sequence, and positioning the sequencing reads on the reference sequence; screening non-repeated areas of the reference sequence, and reserving the non-repeated areas; establishing a matrix of read number in windows through normal samples, analyzing the data of the normal samples, performing statistics on the read number of all the windows in the non-repeated areas, and establishing a probability matrix of the read number and chromosome enpeoids; calculating the copy number, i.e., the A/B/C state, of loci; selecting m continuous loci, i.e., the A state, as micro-duplication loci, and selecting m continuous loci, i.e., the C state, as microdeletion loci; contrasting the micro-duplication loci and the microdeletion loci with the existing CNV (copy number variation) and disease database, performing basic gene annotation and gene function analysis which relates to deletion parts, and annotating with a microdeletion syndrome disease type.
Owner:BEIJING ZHONGYI KANGWEI MEDICAL INSTR

Health data analysis report generating system and method based on gene sequence analysis

The invention relates to a health data analysis report generating system and method based on gene sequence analysis. The system comprises a diseases database module, a manual annotation module, a dataacquisition module, a data analysis module, a data storage module, a template library and a report generation module, wherein the data acquisition module, the data analysis module, the data storage module, the template library and the report generation module are sequentially connected, the diseases database module is connected with the template library, and the manual annotation module is connected with report generation module. According to the system, a health analysis report is generated by the aid of a mode combining an automatic retrieval diseases database with a manual annotation supplementary information, contents are automatically, conveniently and rapidly searched by a computer, labor is saved, a health analysis report generating link is simplified, Chinese version of gene annotation databases is absent at present, a computer system cannot automatically capture data, the contents of the report can be more all-round by the aid of manual annotation, understanding of readers isfacilitated, and practical application requirements are met.
Owner:江苏医联生物科技有限公司

Method for identifying esophageal squamous cell carcinoma markers on basis of network index difference analysis

ActiveCN108108589AHigh precisionFill in the gaps in the analysisProteomicsGenomicsNODALModularity
The invention belongs to the technical field of bioinformatics, and relates to a method for identifying esophageal squamous cell carcinoma markers on the basis of network index difference analysis. The method comprises the following steps of processing esophageal squamous cell carcinoma gene sample data and normal gene sample data to construct an esophageal squamous cell carcinoma gene interactionnetwork and a normal gene interaction network; using a network module identification method to find out key community structures in the two networks, and performing gene function enrichment analysison the key community structures; extracting same nodes from the two networks, and retaining nodes linked to the same nodes to obtain the two simplified networks; using a global index and a local modular index, analyzing the two simplified networks to obtain genes related to esophageal squamous cell carcinoma; combining a gene function enrichment analysis result with gene annotations and functionalreferences to finally determine candidate markers for diagnosis of esophageal squamous cell carcinoma. A method for studying the esophageal squamous cell carcinoma markers on the basis of gene network difference analysis is further perfected.
Owner:ZHENGZHOU UNIVERSITY OF LIGHT INDUSTRY

Molecular marker coseparated from soybean epidemic disease resisting gene RpsZS18, and application thereof

The invention provides a molecular marker ZCindel246000 coseparated from a soybean epidemic disease resisting gene RpsZS18, and an application thereof. The marker is positioned between the SSR markers ZCSSR33 and ZCSSR46 of a soybean No.2 chromosome, and has a genetic distance of 0cM to the gene RpsZS18. A new SSR marker is exploited by using a soybean SSR marker in an interval and using a soybean genome sequence according to a preliminary positioning result with an F3 column generated through hybridizing and selfing disease resisting variety Zaoshu 18 used as a male parent and a susceptible variety Williams used as a female parent as a mapping colony, and a disease resisting gene contained in the Zaoshu 18 is finely positioned. The disease resisting gene RpsZS18 is positioned between the ZCSSR33 (0.7cM) and ZCSSR46 (2.8cM) of the No.2 chromosome, and is coseparated from an SSR marker Satt172. An RpsZS18 candidate gene is predicated according to gene note in the new positioning interval, the Indel marker ZCindel24600 is exploited according to the candidate gene site sequence difference predicated by resistant and susceptible parents, a colony verification result shows that the marker is a coseparated marker, and the Indel marker can be used in auxiliary breeding of soybean epidemic disease resistance.
Owner:INST OF CROP SCI CHINESE ACAD OF AGRI SCI

Antibiotic drug resistance gene influence factor and difference analysis method

The invention discloses an antibiotic drug resistance gene influence factor and difference analysis method. The method comprises the following steps: inputting sample metagenome data and phenotype information of a corresponding sample; annotating the antibiotic drug-resistant gene to obtain an antibiotic drug-resistant gene abundance file; performing antibiotic drug resistance gene influence factor analysis: performing PERMANOVA analysis to obtain a phenotype which has obvious influence on the antibiotic drug resistance gene; carrying out antibiotic drug resistance gene difference analysis: carrying out two-group mean value comparison by utilizing Wilcoxon test and FDR correction, and carrying out more than two-group mean value comparison by utilizing Kruscal-Wallis test, multiple comparison in a PMCMR packet and FDR correction; and judging the change trend of the content of the antibiotic resistance gene. The antibiotic reference database is better adapted to increase of antibiotic resistance sequences, and the multi-module combinatorial analysis method enables analysis of antibiotic resistance genes to be more comprehensive and systematic; and meanwhile, a data set splitting and recombining method is used for obtaining an intersection of multi-data-set analysis results, so that the reliability of the results is improved.
Owner:DALIAN UNIV OF TECH

Method for analyzing phylogenetic development of babylonia formosae based on complete mitochondrial genomes

PendingCN110714063AFixedAnalysis is convenient and effectiveMicrobiological testing/measurementProteomicsNucleotideCaenogastropoda
The invention discloses a method for analyzing phylogenetic development of babylonia formosae based on complete mitochondrial genomes, and relates to the field of analysis of the phylogenetic development of the babylonia formosae. The method for analyzing phylogenetic development of the babylonia formosae based on the complete mitochondrial genomes comprises the following steps: 1) sample collection: collecting babylonia formosae extracting mitochondrial genomes DNA; 2), disrupting and purifying the mitochondrial genomes DNA and then building a DNA sequencing library; 3), obtaining a DNA cluster; 4), sequencing the babylonia formosae mitochondrial genomes DNA; 5), comparing the babylonia formosae mitochondrial genomes with other babylonias having known sequences, and then noting encoded protein genes; and 6), comparing a nucleotide sequence of each gene of the babylonia formosae extracting mitochondrial genomes DNA and an amino acid sequence deduced by the nucleotide sequence with other caenogastropoda species, and performing series connection and then analyzing the phylogenetic development. According to the phylogenetic analysis method of the babylonia formosae based on the complete mitochondrial genomes disclosed by the invention, based on the complete mitochondrial genomes, the phylogenetic development of the babylonia formosae is analyzed, complete data of the complete mitochondrial genomes of the babylonia formosae are obtained, and thus, phylogenetic development is performed, and analysis is performed conveniently and effectively.
Owner:ZHEJIANG OCEAN UNIV

Monitoring gene silencing and annotating gene function in living cells

The cell-based assays described in the present invention can be used to directly assess the sensitivity and specificity of the gene annotation reagent against its target, and to determine if a non-targeted gene participates in a pathway of interest or is functionally linked to another gene or protein. The combination of annotation reagents with such cell-based assays is useful for mapping genes (proteins) into cellular pathways on a genome-wide scale. Preferred assay embodiments include fluorescence or luminescence assays in intact (live or fixed) cells. Such fluorescence or luminescence assays include high-throughput or high-content assays for protein activity, subcellular localization, post-translational modifications, or interactions of proteins. Suitable assays may include protein-protein interaction assays; protein translocation assays; and post-translational modification assays. The invention can be used to assess the efficacy of any gene silencing experiment, to determine the level of gene silencing that is achieved, and to map novel genes into biochemical pathways, and to identify novel pharmaceutical targets. The results also demonstrate the feasibility of employing this strategy in genome-wide functional annotation efforts.
Owner:ODYSSEY THERA INC

Identification method of markers of esophageal squamous cell carcinoma based on difference analysis of network indicators

ActiveCN108108589BHigh precisionFill in the gaps in the analysisProteomicsGenomicsOncogeneCancer research
The invention belongs to the technical field of bioinformatics, and relates to a method for identifying esophageal squamous cell carcinoma markers on the basis of network index difference analysis. The method comprises the following steps of processing esophageal squamous cell carcinoma gene sample data and normal gene sample data to construct an esophageal squamous cell carcinoma gene interactionnetwork and a normal gene interaction network; using a network module identification method to find out key community structures in the two networks, and performing gene function enrichment analysison the key community structures; extracting same nodes from the two networks, and retaining nodes linked to the same nodes to obtain the two simplified networks; using a global index and a local modular index, analyzing the two simplified networks to obtain genes related to esophageal squamous cell carcinoma; combining a gene function enrichment analysis result with gene annotations and functionalreferences to finally determine candidate markers for diagnosis of esophageal squamous cell carcinoma. A method for studying the esophageal squamous cell carcinoma markers on the basis of gene network difference analysis is further perfected.
Owner:ZHENGZHOU UNIVERSITY OF LIGHT INDUSTRY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products